Resident’s conference Presented by: Gagandeep K Heer, MD (PGY-2)

Slides:



Advertisements
Similar presentations
Arterial Fibrodysplasia
Advertisements

Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
M YOCARDIAL ISCHEMIA Prepared by: Dr. Nehad Ahmed.
AM Report Lauren Galpin, MD MA  “Thromboembolic obstruction of the major pulmonary arteries due to unresolved pulmonary embolism [with pulmonary.
Harvard Medical School Duane S. Pinto, M.D. Director Peripheral Angiographic Core Laboratory, TIMI Data Coordinating Center Director, Cardiology Fellowship.
National Institute for Health and Clinical Excellence.
Aortic Aneurysms Mark A. Farber, MD.
Pathogenesis of Aneurysms
Zehra Eren, M.D.. explain hypertansion and renal disease interaction, describe renovascular diseases describe diagnostic evaluation explan therapy in.
PERIPHERAL VASCULAR DISEASE: A VASCULAR SURGEON’S POINT OF VIEW
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Heart Failure Dr. Meg-angela Christi M. Amores. The term "cardiac failure" means simply failure of the heart to pump enough blood to satisfy the needs.
Epidemiology, Risk Factors, Diagnosis and Intervention of Abdominal Aortic Aneurysms By, Sultan O Al-Sheikh.
Abdominal Aortic Aneurysm (AAA) LECT7 ALI B ALHAILIY.
PRESENTED BY : FATHIMA SHAIK ROLL# 1431 MD 04.  WHAT IS ATHEROSCLEROSIS?  CAUSES  PATHOGENESIS  SIGNS AND SYMPTOMS  COMPLICATIONS  DIAGNOSIS  TREATMENT.
MANAGEMENT HTN IN PREGNANCY. DEFINITIONS The definition of gestational hypertension is somewhat controversial. Some clinicians therefore recommend close.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
20 Cardiovascular Disease and Physical Activity chapter.
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
Rashad MAHMUDOV Central Hospital of Oilworkers, Baku-Azerbaijan
Aortic Aneurysm Dr.mehdi hadadzadeh Cardiovascular surgeon IN THE NAME OF GOD.
Exercise Management Aneurysms Chapter 16. Exercise Management Pathophysiology Aneurysms can be caused by congenital or acquired diseases, are usually.
Renovascular Disease Daniel Shoskes MD, MSc, FRCSC Professor of Surgery/Urology Glickman Urological and Kidney Institute Cleveland Clinic.
Atherosclerosis Part 1 Atherosclerosis The general term for hardening of the arteries The most prevalent form of atherosclerosis is characterized by the.
Atherosclerosis by Sidrah naseem (ug-3). Arteries are blood vessels that carry oxygen and nutrients from your heart to the rest of your body. Healthy.
Renal Artery Stenosis November 12, 2009 Lance D. Dworkin, M.D., and Christopher J. Cooper, M.D. Clinical Practice 2010 년 3 월 23 일 화요일 신장내과 R4 이완수.
BASIC SCIENCE: ATHEROSCLEROSIS 2 February 2006 St Luke’s-Roosevelt Hospital Department of Surgery.
Takayasu’s Disease Arteritis affecting primarily the aorta and its main branches –Leads to segmental stenosis, occlusion, dilatation, and aneurysm formation.
Lower Extremity Vascular Disease
Ross Milner, MDUniversity of Chicago Mark Russo, MD, MS Center for Aortic Diseases.
1 Benign Nephrosclerosis Definition: renal changes in benign hypertension It is always associated with hyaline arteriolosclerosis. mild benign nephrosclerosis.
Radka Adlová Arterial hypertension and preventive cardiology.
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
Although in more than 90% of patients with high blood pressure no underlying causes could be identified, up to 10% of hypertensives have a secondary.
Pathophysiology BMS 243 Vascular Diseases Lecture IV Dr. Aya M. Serry
Hypertension and renovascular hypertension BY Dr. Hayam Hebah Associate professor of Internal Medicine AL Maarefa College.
Faculty of allied medical sciences
Renovascular hypertension Dr Saad Al Shohaib KAUH.
بسم الله الرحمن الرحيم. RENAL ARTERY STENOSIS  Lecture by:  Dr. Zaidan Jayed Zaidan.
BY Dr. Hayam Hebah Associate professor of Internal Medicine AL Maarefa College.
Relationship between coronary and renal artery disease and associated risk factors in hypertensive and diabetic patients undergoing coronary angiography.
KIDNEY & HYPERTENTION 1 Dr. Ruba Nashawati. Kidney Hypertension 2.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
Peripheral Vascular Disease
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
Peripheral Artery Disease (PAD)
Date of download: 7/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Uncertain Value of Renal Artery Interventions:
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
CABG IN DIABETICS DR. SEYED SAEED FARZAM. Introduction Patients with diabetes mellitus Increased incidence of CAD More extensive disease at angiography.
The presence of cardiovascular disease is an important predictor of mortality in patients with end-stage renal disease, as it accounts for almost 50 percent.
신장내과 R4 강혜란 Cardiorenal syndrome (CRS).  Patients with heart failure (HF) who have a reduced GFR -> Mortality ↑  Patients with chronic kidney disease.
Review Renovascular hypertension Department of nephrology R4 최소영.
Renal vascular disease
Renovascular Disease Daniel Shoskes MD, MSc, FRCSC
Renovascular Hypertension
Renal Artery Angioplasty and Stenting: Optimal Patient Selection
Hypertension and renovascular hypertension
TUCOM Internal Medicine 4th class
Diuretics Thiazides are the preferred type of diuretic for treating hypertension, and all are equally effective in lowering blood pressure. In patients.
Complex Ostial Disease of the Aortic Arch Vessels
Renal Unit-Careggi University Hospital-Florence-Italy
The Role of Interventional Treatment for The Failing Grafts
Diagnostic Medical Sonography Program
Diuretics, Kidney Diseases Urine R&M
Management of Heart Failure with Renal Artery Ischemia
Stephen C. Textor, Sanjay Misra, Gustavo S. Oderich 
Hypertension evaluation
Correlation between endothelial function and hypertension
Pathology Of Hypertension
Presentation transcript:

Resident’s conference Presented by: Gagandeep K Heer, MD (PGY-2) Renal Artery Stenosis Resident’s conference Presented by: Gagandeep K Heer, MD (PGY-2)

Background Renal artery stenosis (RAS) is the major cause of renovascular hypertension and it accounts for about 1-10% of the 50 million people in the United States who have hypertension. The incidence is less than 1% of cases of mild to moderate HTN. However, it rises to 10 to 45 % in patients with acute (or superimposed upon a preexisting elevation in blood pressure), severe, or refractory hypertension. Renovascular hypertension (RVHT) denotes nonessential hypertension in which a causal relationship exists between anatomically evident arterial occlusive disease and elevated blood pressure. RVHT is the clinical consequence of renin-angiotensin-aldosterone activation as a result of renal ischemia. RAS is also being increasingly recognized as an important cause of chronic renal insufficiency and end-stage renal disease. Studies suggest that ischemic nephropathy from RAS may be responsible for 5-22% of advanced renal disease in all patients older than 50 years in US.

Causes of RAS Major causes of the renal arterial lesions are: Atherosclerosis —It is the cause of RAS in >2/3rd of the cases. This primarily affects men over the age of 45 and usually involves the aortic orifice or the proximal main renal artery. This disorder is particularly common in patients with diffuse atherosclerosis, but can occur as a relatively isolated renal lesion. Fibromuscular dysplasia — In comparison to atherosclerosis, fibromuscular dysplasia most often affects younger women and typically involves the distal main renal artery or the intrarenal branches. Other less common causes of RAS include: Vasculitis (Takayasu’s arteritis) Dissection of the renal artery. Thromboembolic disease Renal artery aneurysm Renal artery coarctation Extrinsic compression Radiation injury

Pathophysiology Atherosclerotic RAS The initiator of endothelial injury is not clear; however, dyslipidemia, hypertension, cigarette smoking, diabetes mellitus, viral infection, immune injury, and increased homocysteine levels may contribute to endothelial injury. In the atherosclerotic lesion site, endothelium permeability to plasma macromolecules (e.g. LDL) increases, turnover of endothelial cells and smooth muscle cells and intimal macrophages also increases. When atherogenic lipoproteins exceed certain critical levels, the mechanical forces may enhance lipoprotein insudation in these regions, leading to early atheromatous lesions. The sites where the initial atherosclerotic lesions developed are more prone to physiological adaptation to mechanical stress secondary to variations in flow and wall tension (e.g. renal artery site).

Pathophysiology Fibromuscular dysplasia: Fibromuscular dysplasias are uncommon angiopathies associated with heterogeneous histologic changes that may affect the carotid circulation as well as the visceral and peripheral arteries. String of beads is the classic radiographic finding seen in FMD. FMD, as a cause of RAS usually affects young to middle-aged adults, mostly women, but it can also affect children.

Pathophysiology Renal blood flow is 3 to 5 fold greater than the perfusion to other organs because it drives glomerular capillary filtration. Both glomerular capillary hydrostatic pressure and renal blood flow are important determinants of the glomerular filtration rate (GFR). In patients with RAS, the GFR is dependent on angiotensin II and other modulators that maintain the autoregulation system between the afferent and efferent arteries and can fail to maintain the GFR when renal perfusion pressure drops below 70-85 mm Hg. Significant functional impairment of autoregulation, leading to a decrease in the GFR, is not likely to be observed until arterial luminal narrowing exceeds 50%. RVHT develops as a result of increased renin and angiotensin II levels causing vasoconstriction as well as salt and water retention (volume expansion) due to increased aldosterone level.

Pathophysiology Increased secretion of renin accelerates the conversion of angiotensin I to angiotensin II which enhances the adrenal release of aldosterone. Angiotensin II causes vasoconstriction of both afferent and efferent arterioles, with a preferential affect on the efferent side. Under physiologic conditions, efferent tone is essential to maintain intraglomerular pressure. In a kidney rendered ischemic by RAS with a reduced afferent blood flow, the intraglomerular pressure and glomerular filtration are maintained by angiotensin II–mediated efferent vasoconstriction. Removal of the efferent vasoconstriction effect by using angiotensin blockade (e.g. by using ACEI) may reduce GFR by causing decrease in intraglumerular pressure. In patients with RAS, the chronic ischemia produces adaptive changes in the kidney that are more pronounced in the tubular tissue. These changes include atrophy with decreased tubular cell size, patchy inflammation and fibrosis, tubulosclerosis, atrophy of the glomerular capillary tuft, thickening and duplication of the Bowman capsule, and intrarenal arterial medial thickening.

Demographics Race: RVD is less common in African American patients. The incidence rate in 2 studies of patients with severe hypertension was 27-45% in whites compared to 8-19% in African Americans. Sex: While the incidence of atherosclerotic RVD is independent of sex, Crowley et al showed that female sex (as well as older age, elevated serum creatinine level, coronary artery disease, peripheral vascular disease, hypertension, and cerebrovascular disease) is an independent predictor of RVD progression. Age: The incidence of RAS increases with increasing age. In 1964, Holley et al reported data from 295 consecutive autopsies performed in their institution during a 10-month period. The mean age at death was 61 years. In the whole group, the prevalence rate of RAS was 27% of 256 cases identified as having history of hypertension. 56% of these showed significant stenosis (>50% luminal narrowing). Among normotensive patients, the incidence of severe RAS was 17%. Among those older than 70 years, 62% had severe RAS. Another study reported similar results, showing 18% incidence of severe RAS for patients aged 65-74 years and 42% for patients older than 75 years.

Clinical Findings Difficult-to-control hypertension despite adequate medical treatment Hypertension with renal failure or progressive renal insufficiency Accelerated or malignant hypertension Severe hypertension (diastolic blood pressure >120 mm Hg) or resistant hypertension Hypertension with an asymmetric kidney Paradoxical worsening of hypertension with diuretic therapy Onset of hypertension occurring in patients younger than 30 years or older than 50 years Symptoms of atherosclerotic disease elsewhere

Clinical Findings Negative family history of hypertension Cigarette smoking or use of other tobacco products Renal failure with ACE inhibition. An increase in serum creatinine of more than 15% is strongly associated with a high incidence of RVD Recurrent pulmonary edema (flash edema) Advanced fundoscopic changes Systolic-diastolic abdominal bruits (In combination with hypertension, these are suggestive of RVHT) Unexplained renal insufficiency in elderly patients Congestive heart failure with poor control of hypertension and renal insufficiency in the absence of a significant decrease in ejection fraction

Risk factors associated with ischemic renal disease Carotid artery disease Coronary artery disease Diabetes mellitus Hypertension Obesity Old age Peripheral vascular disease (vascular disease in the extremities, e.g. the legs) Smoking Familial history of AD or RAS

Differential diagnosis Acute renal failure Chronic glomerulonephritis Malignant HTN causing renal failure Hypersensitivity nephropathy Nephrosclerosis Essential and other causes of hypertension with renal insufficiency

Mortality/Morbidity In patients with hypertension, atherosclerotic renal artery disease is a strong predictor of increased mortality relative to the general population. In the setting of renal dysfunction, RVHT is associated with the greatest mortality rate. Major complications of RVHT include end-organ damage due to chronically uncontrolled hypertension (CAD, stroke, etc.) and progressive renal insufficiency, which is an important sequel of chronic renal ischemia. HTN may be particularly difficult to control or may require multiple antihypertensive agents (with increased adverse effects and drug interactions). In addition, atherosclerotic RVD frequently occurs in the setting of generalized vascular disease (i.e. cerebral, cardiac, peripheral), with the consequences associated with disease in those vascular beds.

Work-up Laboratory Studies: Serum creatinine and creatinine clearance. 24-hour urine protein: Vascular renal disease is associated with minimal-to-moderate degrees of proteinuria, which are rarely in the nephrotic range. Urinalysis shows absence of red blood cells or red blood cell casts (a hallmark of glomerulonephritis). Serologic tests for SLE or vasculitis should be performed if these conditions are suggested (e.g. antinuclear antibodies, C3, C4, antinuclear cytoplasmic antibodies). Measurement of plasma renin activity: The baseline plasma renin activity is elevated in 50-80% of patients with RVHT. Captopril test: Measuring the increase in the baseline plasma renin activity 1 hour after the administration of 25-50 mg of the ACE inhibitor (captopril) can increase the predictive value of baseline plasma renin activity. Patients with RAS have an exaggerated increase in baseline plasma renin activity, perhaps due to the removal of the normal suppressive effect of high angiotensin II levels on renin secretion in the ischemic kidney. Renal vein renin ratio ≥ 1.5 between stenotic/contralateral kidney are of considerable value in determining functionally important lesions and predicting cure or improvement of HTN with PTA or surgical intervention (although PTA or surgery will also benefit one-third to half the patients without lateralizing renal vein renin ratios).

Imaging Studies Ultrasound/Duplex ultrasound: Renal US may show significant asymmetry of kidney size (i.e. size discrepancy of >1.5 cm). Additionally, US may be useful to determine the presence of a solitary kidney. Duplex ultrasound scanning is a noninvasive diagnostic technique that combines a B-mode ultrasound image with a pulse Doppler unit to obtain flow velocity data. It is noninvasive, relatively inexpensive, and can be used in patients with any level of renal function. Captopril renography: Radionuclide renal imaging can be done using Tc99m DTPA, Tc99m MAG3 or OIH ( orthoiodohippuran). It is a safe and noninvasive way to evaluate renal blood flow and excretory function. When captopril is administered (especially in unilateral RAS), the GFR of stenotic kidney falls by about 30% and the normal kidney exhibits an increase in the GFR. Sensitivity of this test is about 85-90% and specificity of 93-98%. Significant azotemia and bilateral RAS adversely affect this accuracy, making it unsuitable for these situations. CT angiography (Spiral CT): This technique involves the use of IV iodinated contrast material and allows 3-dimensional reconstruction images of the renal arteries. Spiral CT is a useful technique that avoids arterial catheterization and produces accurate images of renal artery anatomy.

Imaging Studies Magnetic resonance angiography: Magnetic resonance angiography (MRA) is a very good noninvasive technique capable of demonstrating the renal vascular anatomy and direct visualization of renal artery lesions without iodinated contrast material. The limitations of MRA are its expense and its contraindication in patients with metallic clips, pacemakers, intraocular metallic devices, or other implants. The sensitivity of MRA > 90% for proximal RAS, 82% for main RAS, and very low ( 0%) for segmental stenosis.

Dynamic gadolinium-enhanced magnetic resonance angiogram (MRA) shows normal renal arteries.

Imaging Renal arteriography: This technique remains the gold standard for the confirmation and identification of renal artery occlusion in persons with IRD. Specialists can perform renal arteriography by conventional aortography, intravenous subtraction angiography, intra-arterial digital subtraction angiography (DSA), or carbon dioxide angiography. Conventional aortography produces excellent radiographic images of the renal artery. It is, however, an invasive procedure that requires an arterial puncture, carries the risk of cholesterol emboli, and uses a moderate amount of contrast material with the risk of contrast-induced acute tubular necrosis (ATN). Low osmolar contrast material can limit the risk of CEN.

Digital subtraction flush aortogram in a 77-year-old normotensive man shows marked left renal artery stenosis and diffuse aortic atheroma. The patient presented with lower-limb claudication.

Digital subtraction flush aortogram in an 83-year-old mildly hypertensive man shows complete occlusion of the left renal artery; only a stub of the artery is visualized. Note the diffuse aortic atheroma. The patient presented with lower-limb claudication.

Aortogram of a 4-year-old child with renovascular hypertension caused by stenosis of the left renal artery.

Flush aortogram in a 32-year-old man with familial hypercholesterolemia and difficult-to-control hypertension. Radiograph shows a complete occlusion of the right renal artery and marked stenosis of the left renal artery.

Left: Flush aortogram in a 63-year-old man with hypertension shows marked stenosis of the right renal artery and complete occlusion of the left renal artery. Note the extensive atheroma in the aorta and iliac arteries. Right: nephrogram-phase image shows a significantly smaller left kidney with a faint nephrogram.

Selection of diagnostic tests Once patients are identified as being at higher risk of RAS, the choice of the best test for diagnosis is controversial. Accurate identification of patients with correctable renovascular hypertension can be difficult with use of standard noninvasive techniques (e.g. sonography, CT angio, MRA) because they provide only indirect evidence of the presence of renal artery lesions. On the other hand, invasive techniques with more accurate diagnostic potential can produce a worsening of renal function because of contrast toxicity and complications related to the procedures themselves (e.g. arterial puncture, catheter-induced atheroembolism).

Selection of diagnostic tests When the history is highly suggestive and no risk for radiocontrast-mediated renal injury is present, an intraarterial DSA or conventional angiogram is the appropriate initial test. In patients at risk, a carbon dioxide angiogram can determine the presence of a stenosis, and the risk of radiocontrast angiogram is imposed only on those individuals are most likely to benefit. Perform a spiral CT scan, MRA, or duplex ultrasonography (depending on availability and local experience) when moderate suspicion of renovascular disease exists. A negative test result indicates that an RAS is highly unlikely, while a positive test result can be followed by renal arteriography.

Selection of Diagnostic Tests Gilfeather et al performed a study evaluating conventional angiography versus gadolinium-enhanced MRA in 54 patients and 107 kidneys. The study showed that in 70 kidneys (65%), the average degree of stenosis reported by readers of both modalities differed by 10% or less. In 22 cases (21%), MRA overestimated the degree of stenosis by more than 10% relative to the results of conventional angiography; in 15 cases (14%), MRA underestimated the stenosis by more than 10%.

Selection of Diagnostic Tests The obvious advantages of conventional angiography are its ability to accurately determine the extent of the lesion and suggesting its clinical importance (by demonstrating post-stenotic dilation) and the ability to concurrently perform endovascular therapy. However, specialists should weigh these advantages against the higher cost and greater morbidity of conventional angiography. All these tests should be done if the pt is a reasonable candidate for revascularization procedure.

Prognosis Images from sequential abdominal aortographs or duplex ultrasound scans in patients with documented renal artery lesions who have been treated medically have shown that progressive arterial obstruction occurs in 42-53% of patients with atherosclerotic RAS, often within the first 2 years of radiographic follow-up. The incidence rate of progression to complete renal artery occlusion in these studies ranges from 9-16%; this often occurs in patients with a high-degree stenosis. In a study of 85 patients at the Cleveland Clinic who were followed for 3-172 months, patients with mild-to-moderate stenosis remained unchanged upon follow-up, and 39% of patients with greater than 75% lesions progressed to total occlusion. The prognosis of patients with RVHT is difficult to ascertain and varies with the extent of the occlusive phenomena, the sensitivity of the individual to antihypertensive therapy, and the efficacy of surgical repair and/or angioplasty. RVHT in the setting of chronic renal ischemia and consequent renal dysfunction has been linked to worse outcomes.

Treatment It is crucial to remember that not all HTN in the presence of anatomic RAS is renovascular HTN. Many normotensive patients and those with essential HTN can also have some degree of RAS and do not need revascularization.

Treatment Interventions appropriate for patients with RAS/RVHT may include Medical therapy Percutaneous transluminal angioplasty (PTA) with or without vascular stent placement Surgical revascularization Intravascular ultrasonography-guided atherectomy

Medical therapy Treatment with antihypertensive drugs is indicated and optimal blood pressure control is essential. ACE inhibitors should be avoided. CCB, beta blockers and many other classes of drugs can be safely used. In many patients, blood pressure can be well controlled with medical therapy. Other risk factors that should be addressed include atherosclerosis, smoking, and hyperlipidemia. Definitive therapy for the RAS should always be considered not only for better control of HTN but also to prevent the development of ischemic nephropathy. In patients with diffuse atherosclerosis, the complication rate with both surgery and angioplasty is relatively high. Medical therapy may be preferred to other treatments many cases after carefully weighing risks and benefits of the invasive intervention.

Percutaneous transluminal angioplasty (PTA) PTA has become the procedure of choice for treatment of symptomatic stenoses. Patency rates after PTA are strongly dependent on the size of the vessel treated and the quality of inflow and outflow through the vessel. Because of the excellent results obtained with renal angioplasty, it is the most commonly performed procedure in symptomatic RAS. Previously, a solitary or transplanted kidney was considered a contraindication for PTA. This is no longer the case and, angioplasty is now considered the procedure of choice for treatment of RAS in these patients.

PTA Technical success is achieved in more than 90% of patients, and patency rates are 90-95% at 2 years for FMD and 80-85% for atherosclerosis. Restenosis requiring repeat angioplasty has been reported in fewer than 10% of patients with FMD and in 8-30% with atherosclerotic stenosis. Improvement in blood pressure control with fewer antihypertensive medications is achieved in 30-35% of fibromuscular lesions and in 50-60% of atherosclerotic lesions. A success rate of 83% has been reported with PTA in RAS associated with renal transplantation.

Left: A balloon angioplasty catheter is seen in situ across the left renal artery stenosis. Right: After angioplasty, an excellent anatomic (and functional) result was achieved.

Left renal artery stenosis After PTA

Vascular stent placement Vascular stenting is considered complementary to PTA. Many vascular stents are now available, which can be either self-expanding or balloon expandable. Drug-eluting stents are also available. Intravascular stents placed during angioplasty may be helpful in the prevention of restenosis. Early results suggest that stenting may prove useful in patients with ostial disease, in those in whom restenosis occurs after PTA, or in those with complications (e.g. renal artery dissection) resulting from PTA. Primary renal artery stenting in patients with atherosclerotic RAS has a high technical success rate and a low complication rate.

Intravascular ultrasonography-guided atherectomy In a single reported case, hypertension secondary to AD was successfully diagnosed with intravascular sonography, and intravascular sonography-guided renal atherectomy was curative.

Surgical revascularization Currently, surgical revascularization is reserved for patients in whom the main renal artery appears completely occluded and in whom the surviving renal parenchyma is vascularized by collaterals. Surgical revascularization might also be used when an ostial stenosis is present with a buttressing atheroma on either side of the ostium.

Surgery Several surgical options are available. The stenotic segment may be excised and the artery resutured directly onto either the aorta or surviving stump. A vein graft may be transplanted or the kidney resected and reimplanted in the iliac fossa with the renal artery anastomosed to the iliac artery. Another novel method involves a splenectomy and anastomoses of the splenic artery to the renal artery when RAS involves the left kidney. The underlying diagnosis determines the results of this surgery. With advanced diffuse atherosclerosis, surgery may become less feasible because the certainty that the RAS is the cause of the hypertension is less and the prognosis may be determined by comorbidities.

Surgery A potential complication of surgery is the release of cholesterol emboli during the surgery which can cause renal failure; however, 80-90% of patients undergoing operation for atherosclerotic RAS benefit with cure or improvement. The perioperative mortality rate is less than 5%. In patients with FMD, the cure rate is as high as 80%, and morbidity rates are low. However, these results are not significantly better than what can be achieved with renal angioplasty, at less morbidity, mortality, cost, and inconvenience. In patients with diffuse atherosclerosis, the complication rate with both surgery and angioplasty is relatively high.

Criteria for Revascularization All patients with bilateral stenosis and stenosis in a solitary functioning kidney are candidates for revascularization, regardless of whether they have renal insufficiency. When renal insufficiency is present, patients with unilateral stenosis are also possible candidates for revascularization

Criteria for Revascularization When renal function is normal or nearly normal, specialists recommend revascularization if the patient meets the following criteria: The degree of stenosis is more than 80-85%. The degree of stenosis is 50-80%, and captopril-enhanced scintigraphy findings demonstrate an activation of intrarenal renin angiotensin system. Conversely, physicians can choose observation instead of revascularization (serial imaging every 6 mo with duplex scanning, accurate correction of dyslipidemia, use of drugs that block platelet aggregation) when the patient meets the following criteria: Stenosis is 50-80%, and scintigraphy findings are negative. The degree of stenosis is less than 50%.

Criteria for Revascularization When renal insufficiency is present and the objective is recovery of renal function together with prevention of further renal function impairment, the prerequisites for revascularization are as follows: The serum creatinine level is lower than 4 mg/dL. The serum creatinine level is higher than 4 mg/dL but with a possible recent renal artery thrombosis. When these conditions are satisfied, revascularization can be done if the following apply: The degree of stenosis is more than 80%. The serum creatinine level is increased after administration of ACE inhibitors. The degree of stenosis is 50-80%, and the scintigraphy findings are positive.

When to chose conservative therapy Restrict conservative treatment in patients with an established diagnosis of IRD only to those with absolute contraindications to surgery or angioplasty or to patients who are likely to succumb due to other comorbid conditions before advancing to end-stage renal disease because of IRD. In these cases, the clinicians have to rely on pharmacologic agents (e.g. combination of calcium channels blockers to control blood pressure and optimize renal perfusion), accepting the high probability of deterioration in renal function.